News Search Results
Feb 20, 2025, 11:50 ET Data Center Storage Market Size Worth $130.23 Billion, Globally, by 2031 Growing at 11.2% CAGR | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 20, 2025, 11:30 ET Modular Data Center Market Size Worth $81.56 Billion, Globally, by 2031 Growing at 17.9% CAGR | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 20, 2025, 11:15 ET Artificial Intelligence Market Size Worth $2,172.63 Billion, Globally, by 2031 Growing at 39.1% CAGR | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 20, 2025, 10:50 ET Piezoelectric Devices Market Size Worth $55.96 Billion, Globally, by 2031 Growing at 7.0% CAGR | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 20, 2025, 10:30 ET Gene Therapy Market to Hit USD 36.55 Billion by 2032 with 19.4% CAGR | MarketsandMarkets™.
market share in the North American gene therapy market. Major share of the country is determined by factors like well-established pharmaceutical and biotechnology sector, rising approvals of innovative gene therapies, increasing incidences of diseases like cancer along with high funding for the life sciences
More news about: MarketsandMarkets
Feb 20, 2025, 10:30 ET Memory Chip Market Size Worth $678.44 Billion, Globally, by 2031 Growing at 14.9% CAGR | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 20, 2025, 09:13 ET CSL Receives Approval in Japan for ANDEMBRY® (garadacimab) Subcutaneous (S.C.) Injection 200mg Pens, a Novel Human Anti-Activated Factor XII Monoclonal Antibody for the Prevention of Acute Attacks of Hereditary Angioedema (HAE)
https://www.cslbehring.co.jp. About CSL CSL (ASX:CSL; USOTC:CSLLY) is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza,
More news about: CSL
Feb 20, 2025, 08:31 ET Psilera Inc. & atai Life Sciences Announce Licensing Agreement for DMT Patent Portfolio
BERLIN, Feb. 20, 2025 /PRNewswire/ -- Psilera, Inc. ("Psilera"), a biotechnology company developing groundbreaking therapies for hard-to-treat neurological disorders and atai Life Sciences ("atai"), a clinical-stage biopharmaceutical
More news about: Psilera, Inc
Feb 20, 2025, 08:30 ET Imagine Pharma Selects Designs for Health as Exclusive Distributor to the Healthcare Professional Market for its New, Science-Backed Dietary Supplement for Wellness and Healthy Aging
imaginepharma.com/platforms/regenerative-medicine/ About Imagine PharmaImagine Pharma is a biotechnology company focused on the development of its IMG-1® polypeptide. Research and development efforts have led to the creation of three distinctive
More news about: Imagine Pharma
Feb 20, 2025, 08:00 ET Chromatin Bioscience Joins JLABS EMEA
About Chromatin BioscienceChromatin Bioscience is a biotechnology company focused on the design and development of synthetic promoters for gene and cell therapies and bioprocessing. Our innovative platform enables
More news about: Chromatin Bioscience
Feb 20, 2025, 08:00 ET TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum
Feb. 20, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) , a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that its CEO will join the
More news about: TC BioPharm
Feb 20, 2025, 08:00 ET Metaba and MAX BioPharma Announce Breakthrough Progress on Next-Generation Oxysterol-Based Antibiotics
oxysterol-based antibiotics through preclinical and clinical development. About Metaba, LLC.Metaba is a privately held biotechnology company based in Santa Monica, California, focused on developing first-in-class antibiotic solutions to address
More news about: MAX BioPharma
Feb 20, 2025, 07:42 ET BPC Instruments receives order from DairyExperts for animal nutrition research
instruments enabling more efficient, reliable, and higher quality research and analysis for industries in renewable bioenergy and environmental biotechnology. The result is not only higher accuracy and precision, but also a significant reduction in time consumption and labor requirement for performing
More news about: BPC Instruments AB
Feb 20, 2025, 07:30 ET Immunic's Oral IMU-856 Demonstrated Dose-Dependent Increase of GLP-1 in Celiac Disease Patients and Corresponding Effects in Preclinical Testing
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today
More news about: Immunic, Inc.
Feb 20, 2025, 05:45 ET ICON Public Limited Company Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 11, 2025 to Discuss Your Rights - ICLR
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: The Gross Law Firm
Feb 20, 2025, 05:27 ET NaviFUS Corp. avanza en la medicina de precisión no invasiva para trastornos cerebrales
Himalaya Venture Capital) y Max Wu (Spring Foundation de NCTU). Colabora con YoungTek Electronics Corp., Genovate Biotechnology Co., Ltd. y la Focused Ultrasound Foundation, dirigida por el doctor Neal Kassell. Estas asociaciones aceleran el
More news about: NaviFUS Corp.
Feb 20, 2025, 04:46 ET Oncoinvent ASA: Invitation to Result Presentation Q4 2024
www.oncoinvent.com. There will be a possibility for Q&A through the MS Teams Webinar. About Oncoinvent Oncoinvent is a clinical-stage biotechnology company developing novel radiopharmaceutical therapies against cancer. The lead product candidate, Radspherin, uses the alpha-emitting radionuclide
More news about: Oncoinvent AS
Feb 20, 2025, 02:31 ET Harbour BioMed and Insilico Medicine Achieve Strategic Collaboration to Advance AI-Driven Antibody Discovery and Development
therapeutics focusing on immunology and oncology, and Insilico Medicine ("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, today announced a strategic collaboration to accelerate the discovery and development of innovative therapeutic antibodies, leveraging
More news about: Harbour BioMed
Feb 20, 2025, 00:39 ET NaviFUS Corp. Fortschritte in der nicht-invasiven Präzisionsmedizin für Hirnkrankheiten mit Taiwans Chip-Technologie
Himalaya Venture Capital), und Max Wu (Spring Foundation of NCTU). Es arbeitet mit YoungTek Electronics Corp., Genovate Biotechnology Co. und der Focused Ultrasound Foundation unter der Leitung von Dr. Neal Kassell zusammen. Diese Partnerschaften
More news about: NaviFUS Corp.
Feb 20, 2025, 00:35 ET NaviFUS Corp. La technologie des puces électroniques de Taïwan fait progresser la médecine de précision non invasive pour les troubles cérébraux
Venture Capital) et Max Wu (Spring Foundation of NCTU). Elle collabore avec YoungTek Electronics Corp, Genovate Biotechnology Co, Ltd et la Focused Ultrasound Foundation, dirigée par le Dr Neal Kassell. Ces partenariats accélèrent le développement
More news about: NaviFUS Corp.
Feb 19, 2025, 23:08 ET NaviFUS Corp. Advances Non-Invasive Precision Medicine for Brain Disorders with Taiwan's Chip Technology
Venture Capital), and Max Wu (Spring Foundation of NCTU). It collaborates with YoungTek Electronics Corp., Genovate Biotechnology Co., Ltd., and the Focused Ultrasound Foundation, led by Dr. Neal Kassell. These partnerships accelerate development
More news about: NaviFUS Corp.
Feb 19, 2025, 22:45 ET NaviFUS Corp. Leverages Taiwan's Advanced Chip Technology to Lead Non-Invasive Precision Medicine for Brain Disorders
Bily Wang, who contributed to the development of the clinical trial device Model-101. Additionally, collaborations with Genovate Biotechnology Co., Ltd. Specialized in new drug development and Dr. Neal Kassell, Chairman of the Focused Ultrasound Foundation
More news about: NaviFUS Corp.
Feb 19, 2025, 21:16 ET ICLR REMINDER: Kessler Topaz Meltzer & Check, LLP Urges ICLR Investors with Losses to Contact the Firm
insufficient to shield the company from the adverse effects of a significant market downturn; (3) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Kessler Topaz Meltzer & Check, LLP
Feb 19, 2025, 20:21 ET Nona Biosciences Announces Licensing Agreement with the University of Alabama at Birmingham to Support B Cell Development Research
Mass., Feb. 19, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to I™), today announced a licensing agreement with the University
More news about: Nona Biosciences
Feb 19, 2025, 16:05 ET BioMarin Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Guidance
Conference ID: 1878833 About BioMarin BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The
More news about: BioMarin Pharmaceutical Inc.